The study suggests that
pediatric brain cancer patients may experience similar side effects of molecularly targeted therapies, and may benefit from efforts to remediate any cognitive deficits.
Not exact matches
The St. Jude Children's Research Hospital - Washington University
Pediatric Cancer Genome Project has identified new mutations in
pediatric brain tumors known as high - grade gliomas (HGGs), which most often occur in the youngest
patients.
Our groundbreaking
Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of
pediatric cancer patients including in children with malignant
brain tumors, and determines whether targeted treatments may be available based upon their personalized tumor genomic sequencing profiles.